177 related articles for article (PubMed ID: 37288964)
1. The vagina as source and target of androgens: implications for treatment of GSM/VVA, including DHEA.
Cipriani S; Maseroli E; Ravelli SA; Vignozzi L
Climacteric; 2023 Aug; 26(4):309-315. PubMed ID: 37288964
[TBL] [Abstract][Full Text] [Related]
2. An overview of dehydroepiandrosterone (EM-760) as a treatment option for genitourinary syndrome of menopause.
Holton M; Thorne C; Goldstein AT
Expert Opin Pharmacother; 2020 Mar; 21(4):409-415. PubMed ID: 31928093
[No Abstract] [Full Text] [Related]
3. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; BSc AB; Martel C; Vaillancourt M; Balser J; Moyneur É;
Menopause; 2018 Nov; 25(11):1339-1353. PubMed ID: 30358731
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
Menopause; 2016 Mar; 23(3):243-56. PubMed ID: 26731686
[TBL] [Abstract][Full Text] [Related]
5. Prasterone: A Review in Vulvovaginal Atrophy.
Heo YA
Drugs Aging; 2019 Aug; 36(8):781-788. PubMed ID: 31290076
[TBL] [Abstract][Full Text] [Related]
6. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Gilbert L; Martel C; Balser J
J Sex Med; 2014 Jul; 11(7):1766-85. PubMed ID: 24774442
[TBL] [Abstract][Full Text] [Related]
7. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.
Simon JA; Goldstein I; Kim NN; Davis SR; Kellogg-Spadt S; Lowenstein L; Pinkerton JV; Stuenkel CA; Traish AM; Archer DF; Bachmann G; Goldstein AT; Nappi RE; Vignozzi L
Menopause; 2018 Jul; 25(7):837-847. PubMed ID: 29870471
[TBL] [Abstract][Full Text] [Related]
8. Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review.
Portman DJ; Goldstein SR; Kagan R
Climacteric; 2019 Feb; 22(1):65-72. PubMed ID: 30554531
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10μg estradiol on symptoms of vulvovaginal atrophy.
Archer DF; Labrie F; Montesino M; Martel C
J Steroid Biochem Mol Biol; 2017 Nov; 174():1-8. PubMed ID: 28323042
[TBL] [Abstract][Full Text] [Related]
10. Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.
Labrie F; Derogatis L; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
J Sex Med; 2015 Dec; 12(12):2401-12. PubMed ID: 26597311
[TBL] [Abstract][Full Text] [Related]
11. Science of intracrinology in postmenopausal women.
Labrie F; Bélanger A; Pelletier G; Martel C; Archer DF; Utian WH
Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
[TBL] [Abstract][Full Text] [Related]
12. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
Labrie F; Martel C; Bérubé R; Côté I; Labrie C; Cusan L; Gomez JL
J Steroid Biochem Mol Biol; 2013 Nov; 138():359-67. PubMed ID: 23954500
[TBL] [Abstract][Full Text] [Related]
13. Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study.
Matarazzo MG; Sarpietro G; Fiorito D; Di Pasqua S; Ingrassano S; Panella MM; Cianci A; Caruso S
Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():67-71. PubMed ID: 34167036
[TBL] [Abstract][Full Text] [Related]
14. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
The NAMS 2020 GSM Position Statement Editorial Panel
Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
[TBL] [Abstract][Full Text] [Related]
15. The role of hormone therapy in urogenital health after menopause.
Nappi RE; Cucinella L; Martini E; Cassani C
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101595. PubMed ID: 34711512
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic effect of dehydroepiandrosterone (DHEA) on vulvovaginal atrophy.
Wang J; Wang L
Pharmacol Res; 2021 Apr; 166():105509. PubMed ID: 33610719
[TBL] [Abstract][Full Text] [Related]
17. Insight on the Intracrinology of Menopause: Androgen Production within the Human Vagina.
Cellai I; Di Stasi V; Comeglio P; Maseroli E; Todisco T; Corno C; Filippi S; Cipriani S; Sorbi F; Fambrini M; Petraglia F; Scavello I; Rastrelli G; Acciai G; Villanelli F; Danza G; Sarchielli E; Guarnieri G; Morelli A; Maggi M; Vignozzi L
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33247714
[TBL] [Abstract][Full Text] [Related]
18. Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause.
Stute P; Bertschy S; Birkhaeuser M; Bitzer J; Ging A; Raggi A; Steimann S; Stute V
Climacteric; 2022 Jun; 25(3):246-256. PubMed ID: 34907824
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone).
Archer DF; Labrie F; Bouchard C; Portman DJ; Koltun W; Cusan L; Labrie C; Côté I; Lavoie L; Martel C; Balser J;
Menopause; 2015 Sep; 22(9):950-63. PubMed ID: 25734980
[TBL] [Abstract][Full Text] [Related]
20. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
